The customer base of Labmate (Asia) encompasses leading research establishments in life sciences of ICAR, ICMR, CSIR labs, universities and major hospitals with research facilities.
CEO: S Viswanathan (Director)
Revenue: Rs 37.44 crore
Start-up Year: 1989
Address: C-Block, I Floor, Baid Mehta Complex, 183, Mount Road, Chennai - 600 015
Labmate (Asia) has many firsts in sourcing cutting edge technology products and bringing them to the life science researchers in India. The company operates many business verticals -drug discovery, biologicals, lab instrumentation and biopharma.
Labmate (Asia) was founded as a partnership company in 1989 with the objective to be the comprehensive partner in India, for the manufacturers worldwide in the field of biotechnology. Later it was incorporated as a private limited company in 1992.
Labmate (Asia) has four divisions – instruments, biologicals, drug discovery and frontier tech and imaging.
The discovery group represents the proteomics platform from Bruker Daltonics and established itself with their mass spectrometers in leading labs in India.
The instrument group represents many lab instruments like Compact FAST PCR from Finnzymes. The other products include gel documentation systems and a wide biopharma range of products including downstream processing systems. The biologicals group represent leaders in enzyme technologies, New England Biolabs and its affiliated companies like Cell signaling & Finnzymes. Labmate (Asia) was the first to introduce magenetic immune cell separations in India, from Miltenyi, Germany.
Labmate (Asia) now as a team of over 60 professionals and provides pre-sales, after service and application support to all its users across the country. Headquartered in Chennai, the company has branches in Delhi, Mumbai, Hyderabad, Bangalore, Chandigarh and Kolkata .
The major achievements in 2006-07 include installations of proteomic platforms in ACTREC, Mumbai, Nicholas Piramal, Mumbai, flow systems in CCMB, IISc, IICT and Biocon. The company has installed industrial lyophiliser at Avesthagen, Bangalore, downstream processing system in Serum Institute, Pune. It has also supplied NEB unique enzymes to leading labs. Labmate (Asia) achieved a growth rate of above 30 percent in 2006-2007 and has set a similar target for the current year. Its goal is to become a leader in the arena of high content screening arena, which is a very important step in drug development.
Labmate (Asia) is the marketing partner of UK-based Genetix, a leading robotics manufacturer, for their microarrayers and microarray scanners in India. The hi-tech instruments from the UK that are available in India, deliver high-throughput gene expression analysis aimed at genomics labs and research and drug discovery firms across India.